Cette page a été traduite automatiquement et l'exactitude de la traduction n'est pas garantie. Veuillez vous référer au version anglaise pour un texte source.

Neuromuscular Fatigue Aetiology Comparison Between Prepubertal Boys and Adults (LENGTH-FATIG)

5 août 2026 mis à jour par: University Hospital, Clermont-Ferrand

Potential factors involved in neuromuscular fatigue were classified into two categories: 1) central factors involving the central nervous system and neural pathways, and 2) peripheral factors occurring within the muscle beyond the neuromuscular junction. In adults, it has been shown that peripheral factors contribute to a large part of the fatigue induced by repeated maximal contractions. However in children, central factors could account for the development of fatigue to a greater extent. Force-generating capacity and musculotendinous stiffness could be two of the discriminatory factors accounting for the differences in the neuromuscular fatigue between children and adults.

Force production capacity and musculotendinous stiffness vary as function of muscle length. Naturally, they could differ depending on the muscle groups studied. The main aim of the present protocol is to compare the effect of knee extensors and ankle plantarflexors length on the development and aetiology of neuromuscular fatigue, in children and adults. The investigators formulated the hypotheses that at short muscle length force and low musculotendinous stiffness, differences in force between children and adults would be reduced. Thus neuromuscular fatigue development and aetiology would be similar between both groups. The results of the present protocol will allow to better understanding of the aetiology of neuromuscular fatigue in children and help improving training or rehabilitation programs.

Aperçu de l'étude

Statut

Complété

Les conditions

Intervention / Traitement

Description détaillée

The study of neuromuscular fatigue in children is a recently topic in the field of sport sciences. Such knowledge could improve the efficiency and security of training and rehabilitation in healthy children and children with diseases like obesity.

The LENGTH-FATIG study will provide knowledge about the peripheral and central mechanisms of the neuromuscular fatigue in children and adults. Fatigue will test for different muscle groups (knee extensors and ankle plantar flexors) at different muscle lengths (short, optimal and long).

During high-intensity exercise, prepubertal children are more resistant to fatigue than adults. Contributions of the central and peripheral components to the development of neuromuscular fatigue are also different between both populations. The reduced children's fatigue coud be particularly related to a lower peripheral (i.e. muscular) fatigue. This might be attributed to the fact that prepubertal children rely more on oxidative than anaerobic metabolism than adults during fatiguing exercise. On the other hand, nervous factors could also explain differences in fatigue between children and adults. However, this topic is scarcely documented and still controversial. To our knowledge, no study has still compared the aetiology of central fatigue (supra-spinal vs. spinal) between children and adults. Only the voluntary activation level had been studied in children, conventionally used to assess central fatigue. But this factor doesn't differentiate spinal and supra-spinal contributions to neuromuscular fatigue development.

The LENGTH-FATIG research project is a physiological and observational study comparing two age groups (adults and children). Subjects will have to perform three randomized fatigue protocols at three muscle lengths (short, optimal and long) with the knee extensors and the ankle plantar flexors.

Data will be analyzed using LabChart 7.3 Pro software (ADInstrument, New South Wales, Australia) and Statistica 8.0 software (StatSoft, Inc.) and significance will be accepted at a two-sided alpha level of p<.05. The normality and homogeneity of the variables will be checked respectively from a Shapiro-Wilk test and a Barlett test.

If normality and homogeneity of the variables are verified, absolute values of variables (Force, EMG, NIRS, etc.) will be compared using three factors (age x muscle length x muscle group) analyses of variance (ANOVA) with repeated measures. If analyses reveal a significant effect of any factor or interaction of factors, post-hoc Newman-Keuls tests will be performed to determine differences between the different conditions.

If, on the contrary, normality and homogeneity of the variables are not verified, the effects of muscle length, muscle group and age will be evaluated using a Friedman test. If the tests show significant effects, comparisons of the different conditions will be performed using Mann-Whitney and Wilcoxon tests.

Type d'étude

Observationnel

Inscription (Réel)

50

Contacts et emplacements

Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.

Lieux d'étude

      • Clermont-Ferrand, France, 63003
        • CHU clermont-ferrand

Critères de participation

Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.

Critère d'éligibilité

Âges éligibles pour étudier

8 ans à 35 ans (Enfant, Adulte)

Accepte les volontaires sains

Oui

Méthode d'échantillonnage

Échantillon non probabiliste

Population étudiée

prepubertal boys and adults

La description

Inclusion Criteria:

  • Boys aged 8 to 11 years old, Tanner stages 1 to 3
  • Male aged 18 to 35 years old
  • Non-smoker
  • Moderate physical activity level (< 4h/week)
  • Covered by a social health insurance
  • Consent form signed by participants and/or legal guardians.

Exclusion Criteria:

  • Competitive training
  • Cardiac or pulmonary diseases
  • Epileptic seizures past history
  • Magnetic field contraindication (including cardiac valve, pacemaker, prosthesis material, ferro-magnetic foreign body, cochlear implant and ocular prosthesis material.

Plan d'étude

Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.

Comment l'étude est-elle conçue ?

Détails de conception

Cohortes et interventions

Groupe / Cohorte
Intervention / Traitement
knee extensors
The main aim of the present protocol is to compare the effect of knee extensors and ankle plantarflexors length on the development and aetiology of neuromuscular fatigue, in children and adults
ankle plantar
The main aim of the present protocol is to compare the effect of knee extensors and ankle plantarflexors length on the development and aetiology of neuromuscular fatigue, in children and adults

Que mesure l'étude ?

Principaux critères de jugement

Mesure des résultats
Délai
Maximal torque of knee extensors
Délai: once a week during six weeks.
once a week during six weeks.
ankle plantar flexors joint (in N.m) measured with a dynamometer.
Délai: once a week during six weeks.
once a week during six weeks.

Mesures de résultats secondaires

Mesure des résultats
Délai
Doublet torque amplitude (100Hz, in N.m) evoked using magnetic nerve stimulation at rest
Délai: once a week during six weeks.
once a week during six weeks.
Muscular tissue oxygenation (in μmol.L-1) measured at skin surface by Near-infrared spectroscopy.
Délai: once a week during six weeks
once a week during six weeks
Compound muscle action potential amplitude (i.e. M-wave ; in mV) evoked by supramaximal magnetic nerve stimulation and measured by surface Electromyography (EMG).
Délai: once a week during six weeks
once a week during six weeks
High frequency doublet (100Hz)/low frequency doublet (10Hz) ratio
Délai: once a week during six weeks
once a week during six weeks
fascicule length (mm) measured by B-mode real time ultrasound scanner.
Délai: once a week during six weeks
once a week during six weeks
pennation angle (degree) measured by B-mode real time ultrasound scanner.
Délai: once a week during six weeks
once a week during six weeks
Voluntary activation level (in %) assessed by using the twitch interpolation technique.
Délai: once a week during six weeks
once a week during six weeks
EMG signal Root mean square of EMG signal during isometric maximal voluntary contractions.
Délai: once a week during six weeks
once a week during six weeks
Hoffman reflex amplitude (i.e. H-reflex ; in mV) evoked by submaximal magnetic nerve stimulation measured by surface Electromyography (EMG).
Délai: once a week during six weeks
once a week during six weeks
Cerebral tissue oxygenation (in μmol.L-1) measured at skin surface by Near-infrared spectroscopy
Délai: once a week during six weeks
once a week during six weeks

Collaborateurs et enquêteurs

C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.

Les enquêteurs

  • Chercheur principal: Martine DUCLOS, University Hospital, Clermont-Ferrand

Publications et liens utiles

La personne responsable de la saisie des informations sur l'étude fournit volontairement ces publications. Il peut s'agir de tout ce qui concerne l'étude.

Dates d'enregistrement des études

Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.

Dates principales de l'étude

Début de l'étude (Réel)

13 février 2017

Achèvement primaire (Réel)

20 novembre 2017

Achèvement de l'étude (Réel)

20 novembre 2017

Dates d'inscription aux études

Première soumission

3 février 2017

Première soumission répondant aux critères de contrôle qualité

9 février 2017

Première publication (Réel)

10 février 2017

Mises à jour des dossiers d'étude

Dernière mise à jour publiée (Réel)

7 août 2026

Dernière mise à jour soumise répondant aux critères de contrôle qualité

5 août 2026

Dernière vérification

1 août 2026

Plus d'information

Termes liés à cette étude

Termes MeSH pertinents supplémentaires

Autres numéros d'identification d'étude

  • CHU-304
  • 2016-A00827-44 (Autre identifiant: 2016-A00827-44)

Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .

S'abonner